Press release
Hearing Loss Clinical Trial Pipeline Gains Momentum: 30+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
DelveInsight's, "Hearing Loss Pipeline Insight 2026" report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Hearing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Stay ahead with the latest insights! Download DelveInsight's comprehensive Hearing Loss Pipeline Report @ Hearing Loss Pipeline Outlook Report [https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Hearing Loss Pipeline Report
* On May 22, 2026- Sound Pharmaceuticals Incorporated initiated a clinical trial is to learn about the effects of drug SPI-1005 in adults receiving a cochlear implant with a long electrode array (FLEX26 or greater) from MED-EL Cochlear Implant Systems into one ear.
* On May 05, 2026- Regeneron Pharmaceuticals announced a phase 1/2 study of an investigational new drug called DB-OTO. DB-OTO is a gene therapy that is being developed to treat children who have hearing loss due to changes in the otoferlin gene.
* DelveInsight's Hearing Loss pipeline report depicts a robust space with 30+ active players working to develop 35+ pipeline therapies for Hearing Loss treatment.
* The leading Hearing Loss Companies such as Sensorion, AudioCure Pharma GmbH, Acousia Therapeutics, Neuracle Science, Regeneron Pharmaceuticals, Sound Pharmaceuticals, PAEAN Biotechnology and others.
* Promising Hearing Loss Therapies such as AM-111, FX-322, AUT00063, FX-322 (One Dose), AC102 Gel, Prednisolone, OTO-413, and others.
Access DelveInsight's in-depth Hearing Loss Pipeline Analysis for a closer look at promising breakthroughs @ Hearing Loss Clinical Trials and Studies [https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Hearing Loss Overview
Hearing loss refers to a partial or total inability to hear, which can be present at birth or develop later in life. It can affect one or both ears and is categorized into three main types: conductive hearing loss, caused by issues in the outer or middle ear; sensorineural hearing loss, stemming from damage to the inner ear or auditory nerve; and mixed hearing loss, which involves both conductive and sensorineural components. Hearing loss can manifest through various signs and symptoms, often developing gradually and becoming noticeable over time. Common indicators include difficulty hearing conversations, especially in noisy environments, frequently asking others to repeat themselves, and needing to increase the volume on devices like televisions or radios compared to others. Individuals may also experience muffled sounds, misunderstandings during conversations, and fatigue from concentrating on listening.
Hearing Loss Emerging Drugs Profile
* SENS-401: Sensorion
SENS-401 (Arazasetron), Sensorion's clinical stage drug candidate, is an orally available small molecule that aims to protect and preserve inner ear tissue from damage responsible of progressive or sequelae hearing impairment. Sensorion currently develops SENS-401 in a Phase 2 clinical trial for the prevention of Cisplatin-Induced Ototoxicity and has completed a Phase 2a study to prevent residual hearing loss in patients scheduled for cochlear implantation. SENS-401 has been granted Orphan Drug Designation by the EMA in Europe for the treatment of sudden sensorineural hearing loss, and by the FDA in the US for the prevention of platinum-induced ototoxicity in pediatric population. Currently, the drug is in Phase II/III stage of its clinical trial for the treatment of Hearing Loss.
* ACOU-085: Acousia Therapeutics
ACOU085 is a first-in-class, small-molecule, etiology-agnostic otoprotective drug candidate delivered using standard, transtympanic administration of a proprietary, slow-release gel formulation. Ototoxic hearing loss is a typical, severe, and permanent side effect of cisplatin treatment and is a consequence of irreversible damage to the sensory cells in the inner ear, the so-called outer hair cells (OHCs). ACOU085 modulates a biologically validated target, the KCNQ4-encoded Kv7.4 potassium channel of the OHCs, and has demonstrated significant potential to reduce cisplatin-induced hearing loss and preserve outer hair cells from ototoxicity in preclinical models. Currently, the drug is in Phase II stage of its clinical trial for the treatment of hearing loss.
* NS101: Neuracle Science
NS101 is a monoclonal antibody developed by Neuracle Science Co., Ltd., targeting TAFA5, a protein associated with neurodegenerative diseases such as sensorineural hearing loss and Alzheimer's disease. By modulating TAFA5 activity, NS101 aims to restore neural function and mitigate disease progression. Currently, NS101 is undergoing Phase I/II clinical trials to evaluate its safety, tolerability, pharmacokinetics, and preliminary efficacy in both healthy volunteers and patients with sudden sensorineural hearing loss.
Get a detailed analysis of the latest innovations in the Hearing Loss pipeline @ Hearing Loss Unmet Needs [https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Hearing Loss Companies
Sensorion, AudioCure Pharma GmbH, Acousia Therapeutics, Neuracle Science, Regeneron Pharmaceuticals, Sound Pharmaceuticals, PAEAN Biotechnology and others.
Hearing Loss pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Intravenous
* Subcutaneous
* Parenteral
* Topical
Hearing Loss Products have been categorized under various Molecule types such as
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
Download DelveInsight's latest report to gain strategic insights into upcoming therapies and key developments @ Hearing Loss Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Hearing Loss Pipeline Report
* Coverage- Global
* Hearing Loss Companies- Acousia Therapeutics, Decibel Therapeutics, Otonomy Inc., Sensorion, Autifony Therapeutics, Auris Medical, Sound Pharmaceuticals, Anida Pharma Inc., Gateway Biotechnology, Myrtelle Inc., Lineage Cell Therapeutics, Inc., Altamira Therapeutics, Hoba Therapeutics, Rinri Therapeutics, Autifony Therapeutics, Otologic Pharmaceutics, Audion Therapeutics, Perha Pharmaceuticals, Applied Genetic Technologies Corporation, Akouos, Inc., Oricula Therapeutics, Spiral Therapeutics, Pipeline Therapeutics, Prime Medicine, Boehringer Ingelheim, Autigen, Heyu (Suzhou) Pharmaceutical Technology Co., Ltd, Astellas Pharma, Mogrify Limited and others.
* Hearing Loss Therapies- AM-111, FX-322, AUT00063, FX-322 (One Dose), AC102 Gel, Prednisolone, OTO-413, andothers.
* Hearing Loss Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Hearing Loss Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Find out in DelveInsight's exclusive Hearing Loss Pipeline Report-access it now! @ Hearing Loss Emerging Drugs and Major Companies [https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Hearing Loss: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Hearing Loss- DelveInsight's Analytical Perspective
* Mid Stage Products (Phase II/III)
* SENS-401: Sensorion
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I/II)
* OTO-413: Otonomy Inc.
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* ACOU085: Acousia Therapeutics
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Research programme: Hearing Loss: Autifony Therapeutics
* Drug profiles in the detailed report.....
* Inactive Products
* Hearing Loss- Unmet Needs
* Hearing Loss- Market Drivers and Barriers
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hearing-loss-clinical-trial-pipeline-gains-momentum-30-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/hearing-loss-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hearing Loss Clinical Trial Pipeline Gains Momentum: 30+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight here
News-ID: 4526520 • Views: …
More Releases from ABNewswire
How to Choose the Best Aluminum French Doors for Homes
Picking out the right French doors for your home isn't just about how they look - there's a lot more to think about. John Smith from Aluminum Innovations, who really knows his stuff, once said, "The ideal French aluminum doors should strike a perfect balance between style, security, and energy efficiency." That really hits home because choosing French Aluminum Doors [https://www.sayyas.net/french-aluminum-doors/] is all about understanding all those factors.A lot of…
2026 Best Pointer Tire Pressure Gauge for Accurate Readings?
When it comes to car safety, keeping your tire pressure just right is seriously important. The Pointer Tire Pressure Gauge [https://www.gdseapeng.com/pointer-tire-pressure-gauge/]really stands out as a trustworthy tool for the job. I had a chat with John Smith, a tire expert over at TireTech Innovations, and he mentioned, "Getting an Accurate Tire Pressure [https://www.gdseapeng.com/accurate-tire-pressure/] reading can actually make a difference in how well your car performs and how safe you are."Picking…
Crimp-free Solar Cconnectors: Making Photovoltaic Connections More Convenient
KUIQ X Crimp-free [https://www.slocable.com.cn/crimp-free-connector-solar-connector-product/] solar connectors are a new type of connection component for photovoltaic systems. They eliminate the need for specialized crimping tools, utilizing their own structure to achieve a tight connection between the cable and the terminal. They are widely used in rooftop photovoltaic systems, outdoor power stations, vand emergency repairs. They are particularly suitable for outdoor environments where specialized tools are lacking, significantly reducing labor costs.
Slocable [https://www.slocable.com.cn/solar-connector-electrical-accessories/]possesses…
Silicone-lined buttons for the vehicle's center console
Image: https://ecdn6.globalso.com/upload/p/1620/image_other/2026-06/key-1.png
As the automotive industry advances toward greater intelligence and electrification, the cockpit has evolved beyond a mere control space into a primary touchpoint where users experience a brand's character. In an era where large screens dominate, the tactile presence of physical buttons has become increasingly valued. How can every press deliver precision, a premium feel, and reliability? CMAI [https://www.cmaisz.com/], a manufacturer of silicone products [https://www.cmaisz.com/customizable-silicon-keypad-for-your-needs-product/], offers an industry-leading solution.
A…
More Releases for Hearing
South County Hearing Services Encourages Regular Hearing Tests for Better Long-T …
Image: https://www.globalnewslines.com/uploads/2026/07/1784125657.jpg
Narragansett, RI - South County Hearing Services is encouraging adults to make hearing tests a regular part of their healthcare routine. As hearing loss often develops gradually, many people do not recognize the early signs until communication becomes more difficult. Through comprehensive hearing tests, the clinic helps patients identify hearing changes early and provides personalized solutions that improve hearing and quality of life.
Hearing plays an important role in staying…
Doctors Hearing Care Helps Patients Experience Better Hearing with Advanced Hear …
Image: https://www.globalnewslines.com/uploads/2026/06/1782848835.jpg
NEW ALBANY, IN - Doctors Hearing Care continues to help individuals reconnect with the sounds that matter most by providing advanced hearing aids and personalized hearing care in New Albany, Indiana. As hearing technology continues to evolve, the clinic remains committed to helping patients find the right solution through comprehensive evaluations, expert fittings, and ongoing support from an experienced audiologist.
Hearing loss affects millions of adults and often develops gradually,…
Atlantic Hearing Care, Inc. Champions Hearing Health with Expert Audiologists & …
Image: https://www.globalnewslines.com/uploads/2025/08/1754924892.jpg
Swampscott & Peabody, MA - Atlantic Hearing Care, Inc., a locally owned, patient-centered leader in audiological services, is proud to reaffirm its unwavering commitment to superior hearing health care. With two convenient locations in Swampscott and Peabody, Massachusetts, the practice continues to elevate community access to comprehensive hearing evaluations, expert audiologist consultations, and a wide array of advanced hearing aids.
As hearing loss affects millions, impacting communication, cognition and emotional…
Audio Help Hearing Centers Elevates Hearing Care with Expert Audiologists and Ad …
Image: https://www.globalnewslines.com/uploads/2025/05/1748357801.jpg
NEW YORK, NY - Audio Help Hearing Centers, a trusted leader in hearing healthcare, continues to set the standard for excellence by offering comprehensive hearing services through its team of expert audiologists. With convenient locations across Chelsea, Columbus Circle, Park Avenue, Scarsdale, and Stamford, Audio Help remains committed to delivering personalized care and the latest in hearing aid technology.
At Audio Help Hearing Centers [https://www.audiohelphearing.com/], patients receive individualized attention from…
Dr George Hearing Centers Expands Hearing Solutions with Custom ITE And Canal He …
Image: https://www.globalnewslines.com/uploads/2025/03/1742895322.jpg
Dr. George Hearing Centers expands its offerings with discreet and high-quality solutions for hearing loss.
Larnaca - March 25, 2025 - Dr. George Hearing Centers recently announced their expansion of innovative hearing solutions with custom In-the-Ear (ITE) and Canal Hearing Aids. This addition to their product lineup reflects the company's endeavour to providing high-quality, personalised hearing care for individuals experiencing hearing loss. The lineup includes Invisible-in-the-canal (IIC), Completely-in-the-canal (CIC), In-the-canal…
Global Wireless Hearing Aid Market Driving Future Growth on Wireless Hearing Aid …
Global Wireless Hearing Aid Market 2025:
Global Wireless Hearing Aid Industry Market professional research 2015-2025, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast.
PDF Copy Available at Disconted Price Check Discount @ https://www.marketgrowthinsight.com/discount/90344
The Global Wireless Hearing Aid Market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of…
